Patent details

EP3421033 Title: HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT

Basic Information

Publication number:
EP3421033
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP181797960
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT
French Title of Invention:
FORMULATION D'ATAZANAVIR ET DE COBICISTAT POUR LE TRAITEMENT DU VIH
German Title of Invention:
FORMULIERUNG ZUR HIV-BEHANDLUNG AUS ATAZANAVIR UND COBICISTAT
SPC Number:

Dates

Filing date:
06/10/2014
Grant date:
27/07/2022
EP Publication Date:
02/01/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/07/2022
EP B1 Publication Date:
27/07/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/07/2022
 
 

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312 Steinhausen, Switzerland (CH)

Agent

Name:
MARKS & CLERK LLP
From:
05/10/2022
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
VARIA, Sailesh A.
Address:
United States (US)

2

Name:
KOTTALA, Niranjan Kumar
Address:
India (IN)

3

Name:
KOO, Otilia May Yue
Address:
United States (US)

4

Name:
TAO, Jing
Address:
United States (US)

5

Name:
NIKFAR, Faranak
Address:
United States (US)

Priority

Priority Number:
201361887574 P
Priority Date:
07/10/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/24; A61K 31/4418; A61K 31/5377; A61P 31/12; A61P 31/18; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202230
Publication date:
27/07/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
29/09/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
05/10/2022 Power Of Attorney 1
05/10/2022 Outgoing Correspondence 1